GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Great Basin Scientific Inc (GREY:GBSNQ) » Definitions » Intrinsic Value: Projected FCF

Great Basin Scientific (Great Basin Scientific) Intrinsic Value: Projected FCF : $0.00 (As of May. 17, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Great Basin Scientific Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-17), Great Basin Scientific's Intrinsic Value: Projected FCF is $0.00. The stock price of Great Basin Scientific is $0.015. Therefore, Great Basin Scientific's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Great Basin Scientific's Intrinsic Value: Projected FCF or its related term are showing as below:

GBSNQ's Price-to-Projected-FCF is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.565
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Great Basin Scientific Intrinsic Value: Projected FCF Historical Data

The historical data trend for Great Basin Scientific's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Basin Scientific Intrinsic Value: Projected FCF Chart

Great Basin Scientific Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16
Intrinsic Value: Projected FCF
- - - - -

Great Basin Scientific Quarterly Data
Dec12 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Great Basin Scientific's Intrinsic Value: Projected FCF

For the Diagnostics & Research subindustry, Great Basin Scientific's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Great Basin Scientific's Price-to-Projected-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Great Basin Scientific's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Great Basin Scientific's Price-to-Projected-FCF falls into.



Great Basin Scientific Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Great Basin Scientific  (GREY:GBSNQ) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Great Basin Scientific's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.015/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Great Basin Scientific Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Great Basin Scientific's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Great Basin Scientific (Great Basin Scientific) Business Description

Traded in Other Exchanges
N/A
Address
420 East South Temple, Suite 520, Salt Lake City, UT, USA, 84111
Great Basin Scientific Inc is the United States based molecular diagnostic testing company. It is focused on the development and commercialization of molecular diagnostic platform designed to test for the infectious disease, especially hospital-acquired infections. Molecular diagnostic testing reduces test time from days to hours compared to culture methods. The company's system includes an analyzer, which it provides for the customers' use without charge in the United States, and a diagnostic cartridge, which it sells to the customers. The group derives its revenue from the sale of single-use assays sold in the United States, the European Union, and New Zealand, of which majority of the revenue is generated from the United States.

Great Basin Scientific (Great Basin Scientific) Headlines

No Headlines